AIM ImmunoTech (AIM) shifts to majority-of-votes-cast rule for proposals
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
AIM ImmunoTech Inc. updated its corporate bylaws to change how most shareholder proposals are approved. Effective June 9, 2026, proposals other than director elections will pass with a majority of the votes cast, meaning only votes "for" or "against" are counted and abstentions and broker non-votes are excluded. Previously, these matters required approval by a majority in voting power of the shares present and entitled to vote. The amendment is detailed in an attached bylaw amendment filed as an exhibit.
Positive
- None.
Negative
- None.
Insights
AIM ImmunoTech shifts to a majority-of-votes-cast standard for most shareholder proposals.
AIM ImmunoTech has revised its bylaws so that most stockholder proposals are approved by a majority of votes actually cast, excluding abstentions and broker non-votes. Previously, the test was a majority of the voting power of shares present and entitled to vote.
This change aligns outcomes more closely with active voting decisions and reduces the impact of abstentions on proposal failure. It applies to proposals other than director elections, and still defers to the certificate of incorporation, exchange rules, and applicable law where those set different standards.
8-K Event Classification
2 items: 5.03, 9.01
2 items
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Effective date of bylaw amendment: June 9, 2026
Form type: Form 8-K
Exhibit number: 3.1
3 metrics
Effective date of bylaw amendment
June 9, 2026
Date the new voting standard became effective
Form type
Form 8-K
Current report describing bylaw amendment
Exhibit number
3.1
Amendment to the Amended and Restated Bylaws
Key Terms
Amended and Restated Bylaws, majority of the votes cast, broker non-votes, majority in voting power, +1 more
5 terms
Amended and Restated Bylaws regulatory
"the Company’s Amended and Restated Bylaws (the “Bylaws”), effective as of June 9, 2026."
A company’s amended and restated bylaws are its internal rulebook rewritten to include all changes in one updated document, replacing the old bylaws. For investors, this matters because the bylaws set how the board, shareholders and officers make decisions, hold votes and handle disputes; a new consolidated version can change voting rights, control mechanisms or procedures that affect corporate governance and the value or risk of an investment.
majority of the votes cast financial
"be determined by the affirmative vote of the holders of a majority of the votes cast on the proposal"
broker non-votes financial
"shall only include votes cast for or against the proposal and shall exclude abstentions and broker non-votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
majority in voting power financial
"be decided by the affirmative vote of the holders of a majority in voting power of the shares of stock"
Certificate of Incorporation regulatory
"unless otherwise provided by the Company’s Certificate of Incorporation, the Bylaws, the rules or regulations of any stock exchange"
A certificate of incorporation is an official government document that creates a corporation and records key facts such as its legal name, basic governance structure, and stock authorization—think of it as a company's birth certificate plus its basic rulebook. Investors care because it establishes the company’s legal existence, limits owners’ personal liability, and sets the framework for issuing shares and enforcing shareholder rights, which affects ownership, control and the company’s ability to raise capital.
FAQ
What corporate change did AIM (AIM) disclose in this 8-K filing?
AIM ImmunoTech disclosed a bylaw amendment changing how most shareholder proposals are approved. Proposals other than director elections now require a majority of votes cast, rather than a majority of voting power of shares present and entitled to vote.
When did AIM (AIM) new voting standard for stockholder proposals become effective?
The new voting standard became effective on June 9, 2026. On that date, AIM ImmunoTech’s board approved and adopted the bylaw amendment, immediately updating how non-director proposals are counted at shareholder meetings, subject to any higher standards in governing documents or law.
How did AIM (AIM) voting threshold change for non-director proposals?
Non-director proposals now pass with a majority of votes cast, counting only "for" and "against" votes. Previously, they required a majority in voting power of shares present and entitled to vote, which gave more weight to abstentions and overall attendance levels.
Are abstentions and broker non-votes counted under AIM (AIM) new standard?
Under the new standard, abstentions and broker non-votes are excluded from the vote calculation. Only shares voted "for" or "against" a proposal are considered, which focuses the outcome on actively expressed voting preferences by participating stockholders.
Does AIM (AIM) bylaw change affect director elections?
The described bylaw change explicitly applies to proposals other than the election of directors. Director election standards remain governed separately, along with any requirements in the certificate of incorporation, stock exchange rules, or applicable law.